Rockwell Medical, Inc. RMTI
Set alert
7.07 USD -0.24 -3.28%
At close · Oct 30
7.07 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
6.71 Day range 7.08
5.19 52-week range 12.60
- YTD
- -14.82%
- 1 year
- -34.54%
- Open
- 6.94
- Prev close
- 7.31
- Mkt cap
- 28.50M
- Vol
- 39.54K
- Avg vol
- 25.91K
- EPS
- -1.34
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.71
- High
- 7.08
- Forward P/E
- 30.14
- Beta
- 1.50
- Short ratio
- 1.51
- Inst. own
- 21.27%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.92
- 200-d avg
- 2.38
- 1y target
- 6.50
2Y chart
Events in this range
- Nov 12, 2024Earnings: 0.05; estimate 0.01; surprise 400%
- Nov 14, 2024Rating: Rodman & Renshaw · — → Buy
- Nov 25, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 23, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jul 1, 2026Split: 1 for 10
Signals (79)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| RSI: Overbought | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 1 month ago |
| RSI: Overbought | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 9, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 30, 2026 | 4 months ago |
| RSI: Oversold | Jun 30, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| RSI: Oversold | Jun 11, 2026 | 4 months ago |
| RSI: Oversold | Jun 5, 2026 | 4 months ago |
| RSI: Oversold | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | May 26, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| MACD: Sell Signal | May 6, 2026 | 5 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 26, 2026 | 7 months ago |
| SMA: Bullish | Mar 17, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Feb 20, 2026 | 8 months ago |
| SMA: Bearish | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 10, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 30, 2026 | 9 months ago |
| SMA: Bullish | Jan 20, 2026 | 9 months ago |
| RSI: Overbought | Jan 20, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Jan 6, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 31, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 16, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Nov 17, 2025 | 11 months ago |
| RSI: Oversold | Nov 13, 2025 | 11 months ago |
| RSI: Oversold | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| SMA: Bearish | Sep 18, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Aug 28, 2025 | 1 year ago |
| RSI: Overbought | Aug 27, 2025 | 1 year ago |
| RSI: Overbought | Aug 25, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| SMA: Bearish | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| RSI: Overbought | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| RSI: Oversold | Jun 26, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 21, 2025 | 1 year ago |
| MACD: Buy Signal | May 20, 2025 | 1 year ago |
| MACD: Sell Signal | May 15, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 10, 2025 | 1 year ago |
| RSI: Oversold | Mar 24, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 21, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 12, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| RSI: Oversold | Mar 3, 2025 | 1 year ago |
| RSI: Oversold | Feb 25, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 7, 2025 | 1 year ago |
Key statistics
- Market cap
- 68.19M
- Enterprise value
- 90.33M
- Trailing P/E
- 0.00
- Forward P/E
- 30.14
- PEG ratio
- 0.00
- Price / sales
- 0.72
- Price / book
- 2.89
- EPS (TTM)
- -0.04
- Beta
- 1.50
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -5.06%
- Revenue (TTM)
- 94.37M
- Revenue growth
- 42.90%
- Free cash flow
- -2.37M
- Total cash
- 11.86M
- Total debt
- 14.38M
- Return on equity
- -28.90%
- Shares outstanding
- 32.32M
- Short % of float
- 2.67%
- 50-day average
- 2.92
- 200-day average
- 2.38
Analyst view
Consensus: none
Price target (mean) 6.50 -8.1% downside
Now 7.07
- Target (low)
- 6.00
- Target (mean)
- 6.50
- Target (high)
- 7.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
RMTI Revenue — quarterly 17.78M
RMTI Net income — quarterly -1.17M
RMTI EPS — quarterly -0.34
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.01 | 0.05 | +0.04 | +400.00% |
| Aug 8, 2024 | Jun 1, 2024 | -0.04 | 0.01 | +0.05 | +125.00% |
| May 14, 2024 | Mar 1, 2024 | -0.05 | -0.02 | +0.03 | +60.00% |
| Mar 21, 2024 | Dec 1, 2023 | -0.08 | 0.02 | +0.10 | +125.00% |
| Nov 14, 2023 | Sep 1, 2023 | -0.12 | -0.07 | +0.05 | +41.67% |
| Aug 14, 2023 | Jun 1, 2023 | -0.12 | -0.18 | -0.06 | -50.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 23, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 14, 2024 | Rodman & Renshaw | init | — | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Mar 25, 2024 | HC Wainwright & Co. | main | Buy | Buy |
About Rockwell Medical, Inc.
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- rockwellmed.com
News
- Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026
- Rockwell Medical to Exhibit at ASN Kidney Week 2026
- Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List
- Reviewing Rockwell Medical (NASDAQ:RMTI) & Embecta (NASDAQ:EMBC)
- HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $20 Price Target
- Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
- Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
- Rockwell Medical Announces Second Quarter 2026 Results
- Rockwell Medical Q2 Adj. EPS $(0.04) Beats $(0.23) Estimate, Sales $17.780M Miss $17.837M Estimate
- Rockwell Medical Affirms FY2026 Sales Guidance of $70.000M-$75.000M vs $72.469M Est
Your note
Sign in to keep a note on RMTI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHOLE TIMOTHY | Officer | Sale | Sep 30, 2024 | 55,171 |
| COOPER JOHN G | Director | Stock Award(Grant) | May 20, 2024 | 95,451 |
| LAU JOAN | Director | Stock Award(Grant) | May 20, 2024 | 63,111 |
| NERI JESSE | Officer | Stock Award(Grant) | Mar 13, 2024 | 33,330 |
| NISSENSON ALLEN R | Director | Stock Award(Grant) | May 20, 2024 | 92,597 |
| RADIE ROBERT SAMUEL | Director | Stock Award(Grant) | May 20, 2024 | 93,525 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 11.08% | 3,581,525 | 7.56M | Sep 29, 2024 |
| Vanguard Group Inc | 3.73% | 1,203,910 | 2.54M | Sep 29, 2024 |
| Globeflex Capital L P | 2.30% | 743,256 | 1.57M | Sep 29, 2024 |
| Marshall Wace LLP | 1.57% | 508,674 | 1.07M | Sep 29, 2024 |
| Perkins Capital Management, Inc. | 1.08% | 350,376 | 739.29K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.95% | 307,294 | 648.39K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.51% | 811,895 | 1.71M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.10% | 355,638 | 750.40K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.49% | 157,335 | 331.98K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.21% | 69,300 | 146.22K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.16% | 52,977 | 111.78K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.12% | 37,836 | 79.83K | Oct 30, 2024 |